Edition:
United States

Protagonist Therapeutics Inc (PTGX.OQ)

PTGX.OQ on NASDAQ Stock Exchange Global Market

8.82USD
18 Oct 2018
Change (% chg)

-- (--)
Prev Close
$8.82
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
66,915
52-wk High
$23.68
52-wk Low
$5.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 11.67 -0.408
Mar '18 10.78 -0.363
FY 2017 Dec '17 11.28 -0.151
Sep '17 8.78 -0.285
Jun '17 0.00 -0.888
Mar '17 0.00 -0.841
FY 2016 Dec '16 0.00 -0.767
Sep '16 0.00 -0.503
Jun '16 0.00 -0.500
Mar '16 0.00 -0.804
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 15.21 27.80 7.82 --
Year Ending Dec-18 3 42.27 54.90 35.20 12.33
Year Ending Dec-19 3 24.77 43.80 12.50 28.27
Earnings (per share)
Quarter Ending Dec-18 2 -0.03 0.14 -0.20 --
Year Ending Dec-18 2 -1.30 -1.28 -1.32 -2.70
Year Ending Dec-19 2 -2.09 -1.98 -2.20 -2.15
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.83 33.69
P/E High - Last 5 Yrs. -- 288.76 45.21
P/E Low - Last 5 Yrs. -- 90.17 23.79
Beta -- 0.93 0.88
Price to Sales (TTM) -- 123.60 5.82
Price to Book (MRQ) 5.19 15.31 4.89
Price to Tangible Book (MRQ) 5.20 14.52 6.52
Price to Cash Flow (TTM) -- 70.45 22.95
% Owned Institutions 88.75 14.08 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.55 5.39
Payout Ratio(TTM) -- 16.83 43.91

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 413.48 8.02
Sales (TTM) vs TTM 1 Yr. Ago -- 103.91 5.75
Sales - 5 Yr. Growth Rate -- 30.81 9.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -77.67 24.33 23.65
EPS (TTM) vs TTM 1 Yr. Ago -56.31 -- --
EPS - 5 Yr. Growth Rate -- 37.81 10.95
Capital Spending - 5 Yr. Growth Rate -- 38.61 14.90

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.94 2.25
Current Ratio (MRQ) 7.38 5.34 3.05
LT Debt to Equity (MRQ) 0.00 34.95 12.73
Total Debt to Equity (MRQ) 0.00 36.76 17.15
Interest Coverage (TTM) -5.03 -97.17 37.58

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.15 54.90
Gross Margin - 5 Yr. Avg. -- 49.21 52.43
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -575.88 11.08
Operating Margin (TTM) -- -770.08 4.31
Operating Margin - 5 Yr. Avg. -- -596.20 6.43
Pre-Tax Margin (TTM) -- -732.14 5.36
Pre-Tax Margin - 5 Yr. Avg. -- -601.79 6.86
Net Profit Margin (TTM) -- -733.08 1.64
Net Profit Margin - 5 Yr. Avg. -- -604.76 3.11
Effective Tax Rate (TTM) -- 23.64 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.79 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,788,701 810,573,943
Net Income/Employee (TTM) -1,354,629 1,717,126 95,338,757
Receivable Turnover (TTM) -- 19.81 5.77
Inventory Turnover (TTM) -- 2.38 3.62
Asset Turnover (TTM) 0.00 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -99.82 -1.09 10.92
Return on Assets - 5 Yr. Avg. -- 3.20 12.03
Return on Investment (TTM) -116.32 0.58 14.30
Return on Investment - 5 Yr. Avg. -- 2.28 15.63
Return on Equity (TTM) -643.53 1.62 16.03
Return on Equity - 5 Yr. Avg. -- 3.07 16.90
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -152.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Protagonist Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 99.27%
# of Holders: 88
Total Shares Held: 23,910,776
3 Mo. Net Change: 2,444,535
# New Positions: 0
# Closed Positions: 3
# Increased Positions: 4
# Reduced Positions: 5
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.